Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “3rd Line GIST”

4 trials

Showing 4 of 4 results

Large-scale testing (Phase 3)Study completedNCT01271712
What this trial is testing

Study of Regorafenib as a 3rd-line or Beyond Treatment for Gastrointestinal Stromal Tumors (GIST)

Who this might be right for
Gastrointestinal Stromal Tumors
Bayer 199
Early research (Phase 1)Study completedNCT02686944
What this trial is testing

Evaluate the Safety of Intuvax Administered Intra-tumorally in Patients With Gastrointestinal Stromal Tumors

Who this might be right for
Gastrointestinal Stromal Tumor
Mendus 6
Early research (Phase 1)Study completedNCT01468688
What this trial is testing

A Dose-finding Study of a Combination of Imatinib and BKM120 in the Treatment of 3rd Line GIST Patients

Who this might be right for
3rd Line GIST
Novartis Pharmaceuticals 60
Early research (Phase 1)Study completedNCT01735968
What this trial is testing

A Dose-finding Study of a Combination of Imatinib and BYL719 in the Treatment of 3rd Line GIST Patients

Who this might be right for
3rd Line GIST
Novartis Pharmaceuticals 56

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation